Program Oligonucleotide definition

Program Oligonucleotide means the [***] and [***] obtained from an [***] and [***] and [***] in the performance of the [***] against a [***] that is not a [***].
Sample 1Sample 2Sample 3
Program Oligonucleotide means a MOE Oligonucleotide and/or a Quantification Oligonucleotide conforming to the specifications and criteria set forth in Appendix A (as amended from time to time) for supply and delivery to ISIS.
Sample 1Sample 2Sample 3

Examples of Program Oligonucleotide in a sentence

  • The POSC will meet at least once monthly to review the performance of each Party under the Agreement, to forecast future supply requirements, and to resolve any Program Oligonucleotide supply, quality and/or invoicing issues.

  • It is contemplated by the Parties that all decisions affecting or regarding Program Oligonucleotide specifications (Appendix A) will be the result of informed deliberation and mutual consent of the Program Oligonucleotide Specifications Committee (POSC).

  • Except with respect to patents and patent applications exclusively licensed to IDT in the field of antisense technology, IDT hereby assigns its entire worldwide right, title, and interest, if any, in any Program Oligonucleotide to ISIS, and IDT agrees to take all necessary action to effect any such transfer, and to cooperate with and assist ISIS, at ISIS's expense, in the pursuit, enforcement, and defense of any Intellectual Property rights in any Program Oligonucleotide.

  • On or before the [***] of each month during the Assigned Supply Period, ISIS will supply IDT with a forecast of its intended Program Oligonucleotide orders for the following month.

  • Should ISIS fail to pay the full invoice within [***] Days, IDT will have the right to suspend Program Oligonucleotide manufacturing until the invoice is paid in full.

  • ISIS may terminate this Agreement by providing IDT [***] days written notice if IDT materially fails to comply with any of the Program Oligonucleotide manufacturing or supply requirements set forth in Article 4 and in Appendix A, as amended from time to time.

  • In order to ensure the manufacture and supply to ISIS of optimized Program Oligonucleotides for the duration of this Agreement, IDT and ISIS will form a joint committee of their respective employees to develop, enforce and continuously refine specifications for the manufacture, supply, and receipt of MOE Oligonucleotides and/or Quantification Oligonucleotides (the "Program Oligonucleotide Specifications Committee").

  • Each Party shall appoint a Committee Co-Chair, who will have the joint authority, independent of the POSC, to make any decision regarding modifications to the Program Oligonucleotide specifications.

  • The specifications listed on Appendix A will serve as the Program Oligonucleotide Specifications until amended by POSC.

  • IDT will invoice ISIS at the listed prices less [***] for each Program Oligonucleotide ordered by ISIS and shipped by IDT, and shall reduce ISIS's Customer Deposit by the corresponding [***] sum.

Related to Program Oligonucleotide

  • Antibody means a molecule comprising or containing one or more immunoglobulin variable domains or any fragments, derivatives, variants or modifications thereof that bind to the same antigen.

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Licensed Compound means [***].

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Compounds means any or all of the following chemicals, as the context requires:

  • Antigen means a substance recognized by the body as being foreign; it results in the production of specific antibodies directed against it.

  • Formulation means the combination of various ingredients designed to render the product useful and effective for the purpose claimed, or the form of pesticide as purchased by users;

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • MSAA Indicator Technical Specifications document means, as the context requires, either or both of the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Indicator Technical Specifications November 5, 2018 Version 1.3” and the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Target and Corridor-Setting Guidelines” as they may be amended or replaced from time to time;

  • medicinal product means any substance or combination of substances presented for treating or preventing disease in human beings or animals and any substance or combination of substances which may be administered to human beings or animals with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions in humans or in animals;

  • Vaccine means a specially prepared antigen which, upon administration to a person, will result in immunity and, specifically for the purposes of this rule, shall mean influenza and pneumococcal vaccines.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Reagent means any product other than fuel that is stored on-board the vehicle and is provided to the exhaust after-treatment system upon request of the emission control system.

  • Assay means a laboratory analysis of Crude Petroleum to include the following: A.P.I. Gravity, Reid vapor pressure, composition, pour point, water and sediment content, sulfur content, viscosity, distillation, hydrogen sulfide, flash/boiling point and other characteristics as may be required by Carrier.

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Program Technology means Program Know-How and Program Patents.

  • Corrosion inhibitor means a substance capable of reducing the corrosivity of water toward metal plumbing materials, especially lead and copper, by forming a protective film on the interior surface of those materials.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Non-Microsoft Product means any third-party-branded software, data, service, website or product, unless incorporated by Microsoft in a Product.

  • Milk product or "dairy product" means cottage cheese, dry curd cottage cheese, reduced fat cottage cheese, lowfat cottage cheese, cream, light cream, light whipping cream, heavy cream, heavy whipping cream, whipped cream, whipped light cream, sour cream, acidified sour cream, cultured sour cream, half-and-half, sour half-and-half, acidified sour half-and-half, cultured sour half-and-half, reconstituted or recombined milk and milk products, concentrated milk, concentrated milk products, skim milk, lowfat milk, frozen milk concentrate, flavored milk, eggnog, buttermilk, cultured milk, cultured lowfat milk, cultured skim milk, yogurt, lowfat yogurt, nonfat yogurt, acidified milk, acidified lowfat milk, acidified skim milk, low-sodium milk, low-sodium lowfat milk, low-sodium skim milk, lactose-reduced milk, lactose-reduced lowfat milk, lactose-reduced skim milk, aseptically processed and packaged milk, milk products with added safe and suitable microbial organisms, and any other milk product made by the addition or subtraction of milkfat or addition of safe and suitable optional ingredients for protein, vitamin, or mineral fortification. Unless a product is considered a milk product under this subdivision, milk product does not include dietary products, infant formula, ice cream or other desserts, cheese, or butter. Milk products include the following:

  • Manufacturing Technology means any and all patents, patent applications, know-how, and all intellectual property rights associated therewith that are owned or controlled by Licensor, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno-associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.